Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation

International Journal of Hematology

Volumn 95, Issue 6, 2012, Pages 725-730

  Kamimura, Tomohiko ^a   Miyamoto, Toshihiro ^b   Kawano, Noriaki ^a,c   Numata, Akihiko ^b   Ito, Yoshikiyo ^a   Chong, Yong ^a   Nagafuji, Koji ^b   Teshima, Takanori ^b   Hayashi, Shin ^a   Akashi, Koichi ^b  

^a HARASANSHIN HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

Author keywords

Adult T cell leukemia lymphoma; Allo HSCT; Donor lymphocyte infusion; Graft versus leukemia

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; ETOPOSIDE; HLA ANTIGEN; METHOTREXATE; MITOXANTRONE; PREDNISONE; RANIMUSTINE; VINCRISTINE; VINDESINE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; DISEASE EXACERBATION; DISEASE SEVERITY; DONOR LYMPHOCYTE INFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA RELAPSE; LICHENOID ERUPTION; LYMPHADENOPATHY; MYELOABLATIVE CONDITIONING; RADIATION DOSE; SKIN BIOPSY; SUBCUTANEOUS NODULE; T CELL LEUKEMIA; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LYMPHOCYTE TRANSFUSION; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84865026041     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1056-3     Document Type: Article

References (27)

1. Swerdlow SH, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. 1st ed. Lyon: IARC; 2008.
2. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481-92. (Pubitemid 8180432)
3. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA. 1984;81:2534-7.
4. Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K, et al. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J Clin Oncol. 1988;6: 1088-97.
5. Ishitsuka K, Tamura K. Treatment of adult T-cell leukemia/ lymphoma: past, present, and future. Eur J Haematol. 2008;80: 185-96. (Pubitemid 351253463)
6. Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25: 5458-64. (Pubitemid 350232223)
7. Kami M, Hamaki T, Miyakoshi S, Murashige N, Kanda Y, Tanosaki R, et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol. 2003;120:304-9. (Pubitemid 36194182)
8. Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, Masuda M, et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia. 2005;19:829-34. (Pubitemid 40663104)
9. Yonekura K, Utsunomiya A, Takatsuka Y, Takeuchi S, Tashiro Y, Kanzaki T, et al. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;41:1029-35. (Pubitemid 352034178)
10. Jabbour M, Tuncer H, Castillo J, Butera J, Roy T, Pojani J, et al. Hematopoietic SCT for adult T-cell leukemia/lymphoma: a review. Bone Marrow Transplant. 2011;46:1039-44.
11. Kato K, Kanda Y, Eto T, Muta T, Gondo H, Taniguchi S, et al. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/ lymphoma: retrospective analysis of data from the Japan Marrow Donor Program. Biol Blood Marrow Transplant. 2007;13:90-9. (Pubitemid 46044093)
12. Shiratori S, Yasumoto A, Tanaka J, Shigematsu A, Yamamoto S, Nishio M, et al. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect. Biol Blood Marrow Transplant. 2008;14:817-23. (Pubitemid 351773158)
13. Choi I, Tanosaki R, Uike N, Utsunomiya A, Tomonaga M, Harada M, et al. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials. Bone Marrow Transplant. 2011;46:116-8.
14. Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood. 2004;103:767-76. (Pubitemid 38129531)
15. Ringden O, Karlsson H, Olsson R, Omazic B, Uhlin M. The allogeneic graft-versus-cancer effect. Br J Haematol. 2009;147: 614-33.
16. Roddie C, Peggs KS. Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation. Expert Opin Biol Ther. 2011;11:473-87.
17. Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood. 1993;82:2310-8. (Pubitemid 23304253)
18. Schmid C, Labopin M, Nagler A, Bornhauser M, Finke J, Fassas A, et al. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol. 2007;25:4938-45. (Pubitemid 350225492)
19. Marks DI, Lush R, Cavenagh J, Milligan DW, Schey S, Parker A, et al. The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood. 2002;100:3108-14. (Pubitemid 35217056)
20. McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, et al. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer. 1976;38: 1484-93.
21. Taguchi H, Kinoshita KI, Takatsuki K, Tomonaga M, Araki K, Arima N, et al. An intensive chemotherapy of adult T-cell leukemia/ lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:182-6.
22. Tanosaki R, Uike N, Utsunomiya A, Saburi Y, Masuda M, Tomonaga M, et al. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant. 2008;14:702-8. (Pubitemid 351681417)
23. Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood. 2010;116:1369-76.
24. Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M, et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 2004;64:391-9. (Pubitemid 38114123)
25. Harashima N, Tanosaki R, Shimizu Y, Kurihara K, Masuda T, Okamura J, et al. Identification of two new HLA-A*1101- restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation. J Virol. 2005;79:10088-92. (Pubitemid 41022353)
26. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13:1800-16.
27. Lee KH, Lee JH, Choi SJ, Kim S, Seol M, Lee YS, et al. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant. 2003;32:835-42. (Pubitemid 38455951)